Chan Kwon Park

1.6k total citations
88 papers, 1.1k citations indexed

About

Chan Kwon Park is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Chan Kwon Park has authored 88 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 40 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Chan Kwon Park's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (18 papers). Chan Kwon Park is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (21 papers) and Lung Cancer Research Studies (18 papers). Chan Kwon Park collaborates with scholars based in South Korea, United States and Ireland. Chan Kwon Park's co-authors include Seung Joon Kim, Chang Dong Yeo, Young Kyoon Kim, Sang Haak Lee, Chin Kook Rhee, Hyoung Kyu Yoon, Tae Jung Kim, Ju Sang Kim, Bit Na Kim and Nahyeon Kang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Chan Kwon Park

85 papers receiving 1.1k citations

Peers

Chan Kwon Park
Liyun Cao United States
Yu Dong China
Hee Jeong South Korea
Chan Kwon Park
Citations per year, relative to Chan Kwon Park Chan Kwon Park (= 1×) peers Yoshiko Kaneko

Countries citing papers authored by Chan Kwon Park

Since Specialization
Citations

This map shows the geographic impact of Chan Kwon Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Kwon Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Kwon Park more than expected).

Fields of papers citing papers by Chan Kwon Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chan Kwon Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Kwon Park. The network helps show where Chan Kwon Park may publish in the future.

Co-authorship network of co-authors of Chan Kwon Park

This figure shows the co-authorship network connecting the top 25 collaborators of Chan Kwon Park. A scholar is included among the top collaborators of Chan Kwon Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chan Kwon Park. Chan Kwon Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Hye Seon, Sung Kyoung Kim, Chan Kwon Park, et al.. (2025). Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements. Therapeutic Advances in Medical Oncology. 17. 22760936–22760936.
2.
Hur, Jung, Chin Kook Rhee, Hyoung Kyu Yoon, et al.. (2024). Influence and distinctions of particulate matter exposure across varying etiotypes in chronic obstructive pulmonary disease (COPD) mouse model. Journal of Inflammation. 21(1). 42–42. 1 indexed citations
3.
Park, Cheol‐Kyu, Seung Joon Kim, Chan Kwon Park, et al.. (2024). Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic Cancer. 15(6). 448–457. 2 indexed citations
4.
Lim, Jeong Uk, Hye Seon Kang, Chang Dong Yeo, et al.. (2024). Real‐world study of lazertinib as second‐line or greater treatment in advanced non‐small cell lung cancer. Thoracic Cancer. 15(19). 1513–1521. 1 indexed citations
5.
Choi, Su‐Mi, et al.. (2024). The Outcome of SARS-CoV-2 Infection in Patients with Lymphoma and the Risk Factors for the Development of Pneumonia. Infection and Chemotherapy. 56(3). 378–378. 1 indexed citations
6.
Hur, Jung, Chan Kwon Park, Jeong Uk Lim, et al.. (2023). Tiotropium Bromide Improves Neutrophilic Asthma by Recovering Histone Deacetylase 2 Activity. Journal of Korean Medical Science. 38(12). e91–e91. 2 indexed citations
8.
Lim, Jeong Uk, et al.. (2022). Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease. SHILAP Revista de lepidopterología. 14 indexed citations
9.
Park, Chan Kwon, et al.. (2022). Synergistic effect of roflumilast with dexamethasone in a neutrophilic asthma mouse model. Clinical and Experimental Pharmacology and Physiology. 49(6). 624–632. 4 indexed citations
10.
Jeong, Byeong‐Ho, Sang Haak Lee, Ho Il Yoon, et al.. (2022). Trends and an Online Survey on the Use of Rigid Bronchoscopy in Korea. Journal of Korean Medical Science. 38(3). e13–e13. 4 indexed citations
11.
Lim, Jeong Uk, Hye Seon Kang, Chang Dong Yeo, et al.. (2020). <p>Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study</p>. International Journal of COPD. Volume 15. 3323–3334. 4 indexed citations
13.
Lim, Jeong Uk, Chang Dong Yeo, Chin Kook Rhee, et al.. (2018). Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients. International Journal of COPD. Volume 13. 2139–2146. 19 indexed citations
14.
Lim, Jeong Uk, Chang Dong Yeo, Chin Kook Rhee, et al.. (2015). Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations. PLoS ONE. 10(11). e0142306–e0142306. 27 indexed citations
15.
Lee, Hwa Young, Chin Kook Rhee, Ji Young Kang, et al.. (2015). Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma. The Korean Journal of Internal Medicine. 31(1). 89–97. 19 indexed citations
17.
Rhee, Chin Kook, Ji Young Kang, Chan Kwon Park, et al.. (2014). Effect of nilotinib on airway remodeling in a murine model of chronic asthma. Experimental Lung Research. 40(5). 199–210. 15 indexed citations
18.
Kim, Hye Sook, Jae Sook Sung, Nak‐Jung Kwon, et al.. (2013). Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma. PLoS ONE. 8(12). e81975–e81975. 18 indexed citations
19.
Yoon, Seung Bae, Chan Kwon Park, Min Kyu Kang, et al.. (2011). A Case of Birt-Hogg-Dubé Syndrome Diagnosed by a Folliculin Gene Mutation. The Korean Journal of Internal Medicine. 81(1). 102–106. 1 indexed citations
20.
Rhee, Chin Kook, Jin Woo Kim, Chan Kwon Park, et al.. (2011). Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma. International Archives of Allergy and Immunology. 155(3). 243–251. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026